SCHEMBL3264399

SCHEMBL3264399

[O-][n+]1cccc2cc(O)ccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
POLB P06746 1/20 0.47
CASP6 P55212 1/20 0.47
CYP1A2 P05177 2/20 0.45
ATM Q13315 1/20 0.39
HSP90AA1 P07900 1/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
NQO2 P16083 1/20 0.36
TNNI3 P19429 1/20 0.36
TNNT2 P45379 1/20 0.36
TNNC1 P63316 1/20 0.36
ESR1 P03372 5/20 0.34
ESR2 Q92731 5/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
HSD17B1 P14061 1/20 0.34
CYP2B6 P20813 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1771117 0.84 TNNI3 (0.47) MEN1KMT2APOLBCASP6CYP1A2
SCHEMBL19143244 0.78 CYP1A2 (0.46) MEN1KMT2APOLBCASP6CYP1A2
SCHEMBL607157 0.76 CYP1A2 (0.45) CYP1A2ATMHSP90AA1MAPTHTT
SCHEMBL9332770 0.76 CYP1A2 (0.45) MEN1KMT2APOLBCASP6CYP1A2
SCHEMBL3732872 0.76 ATM (0.39) ATMHSP90AA1MAPTHTTTDP1
SCHEMBL9332778 0.76 ACHE (0.58) MEN1KMT2APOLBCASP6CYP1A2
SCHEMBL1826895 0.76 CYP2A6 (0.45) MEN1KMT2AATMHSP90AA1MAPT
SCHEMBL2798405 0.76 KDM4E (0.45) MEN1KMT2ACYP1A2ATMMAPT
SCHEMBL20996058 0.76 ATM (0.39) ATMHSP90AA1MAPTHTTTDP1
SCHEMBL369538 0.76 CYP2A6 (0.45) MEN1KMT2ACYP1A2ATMHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9556469-B2 Method for classifying the presence or absence of a microorganism in a biological medium COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2017-01-31 US claimed
EP-2723885-B1 METHOD FOR CLASSIFYING THE PRESENCE OR ABSENCE OF A MICROORGANISM IN A BIOLOGICAL MEDIUM COMMISSARIAT L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2015-08-12 EP claimed
US-20140162301-A1 Method for Classifying the Presence or Absence of a Microorganism in a Biological Medium CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2014-06-12 US claimed
CN-103764839-A Method for classifying the presence or absence of a microorganism in a biological medium COMMISSARIAT ENERGIE ATOMIQUE 2014-04-30 CN claimed
US-20060105412-A1 Sulfonate compound and fluorescent probe using the same OSAKA INDUSTRIAL PROMOTION ORGANIZATION (JP) 2006-05-18 US claimed
US-20060105410-A1 Sulfonate compound and fluorescent probe using the same OSAKA INDUSTRIAL PROMOTION ORGANIZATION (JP) 2006-05-18 US claimed
EP-1650200-A1 SULFONATE COMPOUND AND FLUORESCENT PROBE USING THE SAME Osaka Industrial Promotion Organization (JP) 2006-04-26 EP claimed
CN-117384154-A Pyrroloquinolinone compound, synthesis method and application thereof 广州医科大学 2024-01-12 CN disclosed
CN-115611807-A Preparation method of cilostazol intermediate 湖南复瑞生物医药技术有限责任公司 2023-01-17 CN disclosed
CN-107098855-A A kind of method for preparing the quinolinone of 7 hydroxyl 2 上海诺星医药科技有限公司 2017-08-29 CN disclosed
CN-103764839-B For by biological medium presence or absence of microorganism classification method 原子能与替代能源委员会 2017-03-29 CN disclosed
US-9556469-B2 Method for classifying the presence or absence of a microorganism in a biological medium COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2017-01-31 US disclosed
US-9556469-B2 Method for classifying the presence or absence of a microorganism in a biological medium COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2017-01-31 US disclosed
US-20060105410-A1 Sulfonate compound and fluorescent probe using the same OSAKA INDUSTRIAL PROMOTION ORGANIZATION (JP) 2006-05-18 US disclosed
US-20060105412-A1 Sulfonate compound and fluorescent probe using the same OSAKA INDUSTRIAL PROMOTION ORGANIZATION (JP) 2006-05-18 US disclosed
EP-1650200-A1 SULFONATE COMPOUND AND FLUORESCENT PROBE USING THE SAME Osaka Industrial Promotion Organization (JP) 2006-04-26 EP disclosed
EP-1474401-A2 NOVEL ARYL- AND HETEROARYLPIPERAZINES NOVO NORDISK A/S (DK) 2004-11-10 EP disclosed
US-20030236259-A1 Novel aryl- and heteroarylpiperazines HIGH POINT PHARMACEUTICALS, LLC 2003-12-25 US disclosed
WO-2003066604-A2 NOVEL ARYL- AND HETEROARYLPIPERAZINES NOVO NORDISK A/S (DK) 2003-08-14 WO disclosed
CN-1172478-A Quinolone derivative antithrombotic agent OTSUKA PHARMA CO LTD (JP) 1998-02-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060105410-A1 Sulfonate compound and fluorescent probe using the same BRS3, NCOA3, NR4A3 MEN1 3862/4885KMT2A 3690/4885POLB 3276/4885
US-20030236259-A1 Novel aryl- and heteroarylpiperazines HRH3, HRH2, HRH4 MEN1 3565/4885KMT2A 301/4885POLB 4110/4885
US-20060105412-A1 Sulfonate compound and fluorescent probe using the same SLCO1B3, CBR3, SLCO2B1 MEN1 3246/4885KMT2A 3971/4885POLB 2460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.